| 英文摘要 |
H5 subtype highly pathogenic avian influenza (HPAI) viruses have shifted from episodic outbreaks to a sustained global threat. Clade 2.3.4.4b H5N1 now circulates widely in wild birds, repeatedly seeding poultry outbreaks and spilling over into an expanding range of mammalian hosts, consistent with a modern panzootic. Growing mammalian involvement increases opportunities for viral adaptation and reassortment, broadening zoonotic pathways and complicating pandemic risk assessment. The detection of H5N1 in U.S. dairy cattle in 2024 was a key inflection point. There were reports of spread within and between farms, high viral burdens in milk, and secondary infections in cats and other mammals, followed by sporadic infections among exposed workers. Recent H5N1 human infections are frequently mild, including conjunctivitis, and detection is limited by incomplete exposure histories, variation in optimal sampling sites, and heterogeneous viral shedding. Companion animals, particularly cats, appear highly susceptible, and emerging reports implicate contaminated raw milk and possibly raw pet foods in severe feline illness, highlighting new household-level exposure pathways. This review summarizes current evidence for H5 evolution and dispersal, avian and mammalian epidemiology, and the dairy cattle event as a turning point in risk evaluation. Clinical and surveillance implications for human infection are discussed, along with One Health preparedness priorities, including integrated surveillance across wildlife, poultry, and livestock; occupational protection for high-risk workers; risk communication on avoidable exposures, such as unpasteurized milk and raw animal products; and continued development of vaccines and candidate vaccine viruses for rapid response. |